Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | OC-L |
Synonyms | |
Therapy Description |
OC-L is a cancer vaccine prepared by loading dendritic cells with oxidized tumor lysate, which induces anti-tumor immune response (PMID: 23777306). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
OC-L | Autologous OC-L Vaccine | OC-L is a cancer vaccine prepared by loading dendritic cells with oxidized tumor lysate, which induces anti-tumor immune response (PMID: 23777306). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02452775 | Phase I | OC-L | Autologous OC-L Vaccine and Ovarian Cancer | Terminated | USA | 0 |